Purmonen TT, Pänkäläinen E, Turunen JHO, Asseburg C, Martikainen JA. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. AO [Internet]. 2011 Apr. 1 [cited 2026 May 1];50(3):344-52. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/31982